Abstract:Background and aims Endoscopic full-thickness resection (EFTR) has been increasingly applied in the treatment of gastric submucosal tumors (G-SMTs) with explorative intention. This study aimed to compare the efficacy, tolerability, and clinical outcomes of EFTR and surgical intervention for the management of muscularis propria (MP)-derived G-SMTs. Methods Between September 2011 and May 2019, the clinical records of patients with MP-derived G-SMTs undergoing EFTR at our endoscopic unit were collected. A cohort of people with primary MP-derived G-SMTs treated by surgery was matched in a 1:1 ratio to EFTR group with regard to patients’ baseline characteristics, clinicopathologic features of the tumor and the procedure date. The perioperative outcomes and follow-up data were analyzed. Results In total, 62 and 62 patients were enrolled into the surgery and EFTR group, respectively, with median follow-up of 786 days. The size of G-SMTs (with ulceration) ranged from 10 to 90 mm. For patients with tumor smaller than 30 mm, surgery and EFTR group presented comparable procedural success rate (both were 100%), en bloc resection rate (100% vs. 94.7%), tumor capsule rupture rate (0% vs. 5.3%), and pathological R0 resection rate (both were 100%). EFTR had a statistically significant advantage over surgery for estimated blood loss (3.12 ± 5.20 vs. 46.97 ± 60.73 ml, p ≤ 0.001), discrepancy between the pre- and postprocedural hemoglobin level (5.18 ± 5.43 vs. 9.84 ± 8.25 g/L, p = 0.005), bowel function restoration [1 (0–5) vs. 3 (1–5) days, p ≤ 0.001], and hospital cost (28,617.09 ± 6720.78 vs. 33,963.10 ± 13,454.52 Yuan, p = 0.033). The patients with tumor larger than 30 mm showed roughly the same outcomes after comparison analysis of the two groups. However, the clinical data revealed lower en bloc resection rate (75.0% vs. 100%, p = 0.022) and higher tumor capsule rupture rate (25.0% vs. 0%, p = 0.022) for EFTR when compared to surgery. The procedure time, duration of postprocedural fasting and antibiotics usage, and hospital stay of the two groups were equivalent. The occurrence rate of adverse events within postoperative day 7 were 74.2% and 72.6% after EFTR and surgery, respectively ( p = 1.000). No complications occurred during the follow-up. Conclusion For treatment of MP-derived G-SMTs (with or without ulceration), our study showed the feasibility and safety of EFTR, which also provided better results in terms of procedural blood loss, the postoperative bowel function restoration and cost-effectiveness when compared to surgery, whereas the surgery was superior in en bloc resection rate for G-SMTs larger than 30 mm. The postprocedural clinical outcomes seemed to be equivalent in these two resection methods.

Treatment of leakage via metallic stents placements after endoscopic full-thickness resection for esophageal and gastroesophageal junction submucosal tumors.

Resection of the Gastric Submucosal Tumor (G-SMT) Originating from the Muscularis Propria Layer: Comparison of Efficacy, Patients' Tolerability, and Clinical Outcomes Between Endoscopic Full-Thickness Resection and Surgical Resection

Clinical analysis of endoscopic resection for submucosal tumors in the esophagogastric junction

Endoscopic Submucosal Dissection for the Treatment of Large Gastric Submucosal Tumors Originating from the Muscularis Propria Layer: a Single Center Study.

Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos)

Safety and efficacy of a modified endoscopic full-thickness resection technique for gastric submucosal tumors: a case series

Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from muscularis propria layer

Sa1396 Submucosal Tunnel Endoscopic Resection for Submucosal Tumors of the Esophagogastric Junction Originating from the Muscularis Propria Layer: a Feasibility Study

Feasibility and safety of endoscopic full‐thickness resection for submucosal tumors in the upper gastrointestinal tract, including predominantly extraluminal submucosal tumors (with video)

Endoscopic Resection of Submucosal Tumors in Muscularis Propria: the Choice Between Direct Excavation and Tunneling Resection

Membrane-covered Self-Expanding Stents in the Treatment of High-Positioned Esophageal Stenosis or Fistula

The Application of Endoscopic Loop Ligation in Defect Repair Following Endoscopic Full-Thickness Resection of Gastric Submucosal Tumors Originating from the Muscularis Propria Layer.

[Submucosal Tunneling Endoscopic Resection in the Treatment of Esophageal Submucosal Tumors Originating from Muscularis Propria Layer].

Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases.

Deployment of self-expanding membranous metallic stents under fluoroscopic guidance in patients with malignant esophagorespiratory fistulae: a report of 6 patients

The Retrospective Comparison Between Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Excavation for Managing Esophageal Submucosal Tumors Originating from the Muscularis Propria Layer

Postoperative encapsulated hemoperitoneum in a patient with gastric stromal tumor treated by exposed endoscopic full-thickness resection: A case report

Submucosal Tunnel Endoscopic Resection for Extraluminal Tumors: a Novel Endoscopic Method for En Bloc Resection of Predominant Extraluminal Growing Subepithelial Tumors or Extra-Gastrointestinal Tumors (with Videos)

Submucosal Tunneling Endoscopic Resection for Submucosal Tumors in the Proximal Esophagus

Clinical Application Of Metallic Stents In Treatment Of Esophageal Carcinoma

Endoscopic transmural route for dissection of gastric submucosal tumors with extraluminal growth: experience in two cases